Urged on by the medical industry and patients’ groups, the House overwhelmingly approved a bipartisan bill that would speed federal approval of drugs and medical devices and boost biomedical research. The measure’s easy 344-77 passage on Friday came despite objections from consumer organizations and others arguing the measure would erode government safeguards against dangerous and ineffective products.

Click here to read original article